| # | Drug | Count |
|---|---|---|
| 0 | ONABOTULINUMTOXINA | 449 |
| 1 | BOTULINUM TOXIN TYPE A | 111 |
| 2 | INCOBOTULINUMTOXINA | 43 |
| 3 | PRABOTULINUM TOXIN TYPE A | 14 |
| 4 | LEVOTHYROXINE SODIUM | 12 |
| 5 | ERGOCALCIFEROL | 9 |
| 6 | IBUPROFEN | 8 |
| 7 | TOPIRAMATE | 7 |
| 8 | ALPRAZOLAM | 6 |
| 9 | GABAPENTIN | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | APRACLONIDINE | 1 | 0.0090 |
| 1 | BOTULINUM TOXIN TYPE A | 111 | 0.0087 |
| 2 | INCOBOTULINUMTOXINA | 43 | 0.0074 |
| 3 | ONABOTULINUMTOXINA | 449 | 0.0058 |
| 4 | CASTOR OIL | 1 | 0.0052 |
| 5 | FROVATRIPTAN SUCCINATE | 4 | 0.0050 |
| 6 | PRABOTULINUM TOXIN TYPE A | 14 | 0.0037 |
| 7 | NARATRIPTAN | 2 | 0.0014 |
| 8 | DIFLUPREDNATE OPHTHALMIC | 1 | 0.0011 |
| 9 | TAZAROTENE | 1 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Acetylcholine Release Inhibitor [EPC] | 614 |
| 1 | Neuromuscular Blocker [EPC] | 614 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 18 |
| 3 | Benzodiazepine [EPC] | 9 |
| 4 | Provitamin D2 Compound [EPC] | 9 |
| 5 | Corticosteroid [EPC] | 7 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 7 |
| 7 | Vitamin C [EPC] | 6 |
| 8 | Anti-epileptic Agent [EPC] | 5 |
| 9 | Central Nervous System Stimulant [EPC] | 5 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Acetylcholine Release Inhibitor [EPC] | 614 | 0.0062 |
| 1 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 2 | Provitamin D2 Compound [EPC] | 9 | 0.0003 |
| 3 | Barbiturate [EPC] | 3 | 0.0003 |
| 4 | Human alpha-1 Proteinase Inhibitor [EPC] | 1 | 0.0002 |
| 5 | alpha-1 Adrenergic Agonist [EPC] | 1 | 0.0002 |
| 6 | Non-Standardized Insect Allergenic Extract [EPC] | 1 | 0.0002 |
| 7 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 1 | 0.0002 |
| 8 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 4 | 0.0002 |
| 9 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |